2018 BIO IP & Diagnostics Symposium
Warren Woessner, founding shareholder of Schwegman, will be moderating a panel and speaking about patent issues involving medical diagnostic testing at the Bio IP & Diagnostics Symposium on September 28, 2018 in Alexandria, VA.
The Symposium program will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. Sessions will review IP issues for both diagnostics generally and companion diagnostics. Programming will also explore new collaborations and regulatory developments. Biotechnology Innovation Organization (BIO) aims to use this event to inform industry and government alike on how to move the science forward in the current climate.Back to All News